Bijan Salehizadeh

Bijan earned an AB degree in molecular biology from Princeton University, an MS in health policy and an MD in medicine from Columbia University, and an MBA from Harvard Business School.

Dr. Bijan Salehizadeh has 13 years of healthcare operating and investment experience. He co-founded NaviMed Capital, a Washington, D.C.-based firm focused on later-stage healthcare investments. He sits on the board of directors of Hyperion Therapeutics (IPO) and Auris Surgical Robotics, and is an advisor to Kyruus and Procured Health. 

​

Previously, Bijan was a General Partner at Highland Capital Partners, where he focused on venture- and growth-stage healthcare investments. Prior to joining Highland in 2003, Dr. Salehizadeh spent several years in marketing at Medtronic where he worked closely with NaviMed co-founder Brian Canaan. Before Medtronic, he held a variety of senior management roles with HealthCentral, a venture-backed healthcare information technology company that went public in 1999. During his medical training, Bijan conducted research in minimally-invasive heart valves and left ventricular assist devices.

Bijan is a member of Kauffman Fellows Class 9 and served his fellowship under mentor Bob Higgins at Highland Capital Partners.